June 14, 2017
Kaken Pharmaceutical and Swiss biopharma Numab Therapeutics inked a collaboration research pact aiming to identify a multi-specific antibody candidate for the treatment of inflammatory diseases. Under their pact, Kaken will fully fund their research program to identify a lead candidate...read more